PIII News and Press, P3 Health Partners Inc. From 05/10/23

-Capitated revenue increases 11% vs. the same period in the prior year -Q1 2023 operating loss improved 7% vs. the same period in the prior year -Q1 2023 medical margin improvement of 58% vs. the same period in the prior year -Increases Adjusted EBITDA guidance ...

2023-05-03 13:00:53 ET If you’re looking for the best penny stocks to buy, chances are that you’re looking for potential catalysts. This might come in the form of news headlines, social sentiment, speculation, or a mix of different catalysts. One that has stood out for inv...

2023-05-03 08:34:28 ET Aptorum Group  ( APM ) +153% . Akanda  ( AKAN ) +113% . ImmunoGen ( IMGN ) +96% surges ~95% as ovarian cancer drug Elahere shows survival benefit in confirmatory trial. Kiromic BioPharma, Inc. ( KRBP ) +59% ....

Management to host investor call and webcast at 4:30pm ET on May 10, 2023 P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release it...

2023-03-31 10:40:11 ET P3 Health Partners Inc. (PIII) Q4 2022 Earnings Conference Call March 31, 2023, 08:30 AM ET Company Participants Karen Blomquist - Director, IR Sherif Abdou - CEO Atul Kavthekar - CFO Conference Call Participants Brooks O'Neil -...

2023-03-31 07:54:20 ET P3 Health Partners press release ( NASDAQ: PIII ): Q4 GAAP EPS of -$2.26 misses by $0.70 . Revenue of $258.2M (+39.3% Y/Y) beats by $3.2M . For further details see: P3 Health Partners GAAP EPS of -$2.26 misses by $0.70, revenue of $...

2023-03-31 07:16:07 ET P3 Health Partners ( NASDAQ: PIII ) entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific...

Affirming 2023 guidance – introducing year-end medical margin guidance Anticipates reaching Adjusted EBITDA positive in early 2024 Management to Host Conference Call and Webcast March 31, 2023 at 8:30 AM ET P3 Health Partners Inc. (“P3” or the “Co...

P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The le...

Management to host investor call and webcast on March 31, 2023 at 8:30 AM ET P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced that it will now release results ...